[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.237.51.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

November 2019 - July 1883

Decade

Year

Issue

September 17, 2019, Vol 322, No. 11, Pages 1023-1116

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2019;322(11):1023-1025. doi:10.1001/jama.2018.15509
Original Investigation

Effect of Vaginal Mesh Hysteropexy vs Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA. 2019;322(11):1054-1065. doi:10.1001/jama.2019.12812

This randomized clinical trial compares effectiveness and adverse events of transvaginal mesh–augmented hysteropexy vs vaginal hysterectomy with suture apical uterosacral ligament suspension in postmenopausal women with symptomatic uterovaginal prolapse.

Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA. 2019;322(11):1066-1076. doi:10.1001/jama.2019.12467

This superiority trial compared behavioral and pelvic floor muscle therapy plus midurethral sling surgery with midurethral sling surgery alone in treating women with mixed urinary incontinence.

Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Abstract Full Text
free access has active quiz has audio
JAMA. 2019;322(11):1077-1084. doi:10.1001/jama.2019.12843

This randomized trial compares the effects of sacubitril-valsartan vs enalapril on central aortic stiffness and other physiologic indexes in patients with heart failure and reduced ejection fraction.

Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction

Abstract Full Text
has audio
JAMA. 2019;322(11):1085-1095. doi:10.1001/jama.2019.12821

This exploratory cohort study of patients with heart failure with reduced ejection fraction (HFrEF) assesses the association between change in N-terminal pro–B-type natriuretic peptide (NT-proBNP) after starting sacubitril-valsartan and changes in left ventricular ejection fraction, diastolic volume, and other measures of physiologic cardiac function.

Research Letter

Preventive Services Offered in Executive Physicals at Top-Ranked Hospitals

Abstract Full Text
JAMA. 2019;322(11):1101-1103. doi:10.1001/jama.2019.10563

This study describes health services offered by USNWR “best hospitals” in executive physical packages, daylong comprehensive evaluations offering testing and screening of wealthy individuals and corporate leaders.

Viewpoint

Screening for Social Determinants of Health: The Known and Unknown

Abstract Full Text
has audio
JAMA. 2019;322(11):1037-1038. doi:10.1001/jama.2019.10915

This Viewpoint reviews evidence of the effects of screening for social determinants of health and emphasizes the need to assess if screening leads to improvements in case finding, referral to and receipt of social services, and patient outcomes without patient harms.

Psychiatric Practice Patterns and Barriers to the Adoption of Esketamine

Abstract Full Text
JAMA. 2019;322(11):1039-1040. doi:10.1001/jama.2019.10728

In 2019, the US Food and Drug Administration approved esketamine for treatment of major depressive disorder unresponsive to other therapies when given in a health care facility because of its transient effects on vital signs and feelings of dissociation it can produce acutely. This Viewpoint discusses likely barriers to use of the new treatment option given that the drug is expensive, many psychiatrists work in solo or small group settings, do not accept commercial insurance, and may be reluctant to invest in the costly infrastructure necessary to provide it and monitor patients as required after its administration.

Opioid Injection in Rural Areas of the United States: A Potential Obstacle to Ending the HIV Epidemic

Abstract Full Text
JAMA. 2019;322(11):1041-1042. doi:10.1001/jama.2019.10657

In this Viewpoint, Drs Anthony Fauci and Andrea Lerner discuss the rise of injection of opioids in the rural US as an emerging risk factor for HIV infection among traditionally low-risk communities, and calls for interventions to prevent IDU-related HIV transmission—needle-exchange programs, opioid use disorder treatment programs, and increased availability of preexposure prophylaxis (PrEP)—as a means to end the HIV epidemic in the US.

Reducing Pollution From the Health Care Industry

Abstract Full Text
JAMA. 2019;322(11):1043-1044. doi:10.1001/jama.2019.10823

This Viewpoint summarizes what is known about greenhouse gas emissions and pollution generated by health care activities in high-income countries, calls for cooperation between stakeholders (physicians, hospital administrators, regulatory bodies, specialty societies, policy makers, industry) to reduce the environmental footprint of their collective activities, and calls for funding of environmental sustainability science to inform the effort and optimize resource and waste management.

A Piece of My Mind

Who Heals the Healer?

Abstract Full Text
JAMA. 2019;322(11):1045-1046. doi:10.1001/jama.2019.14043

In this narrative medicine essay, an obstetrician-gynecologist struggles with the overwhelming strains of her profession, family obligations, and struggling marriage that together buried her sense of empathy until a grateful patient hugs her, an expression that reaches what she feared had been long extinguished.

Editorial

Pelvic Organ Prolapse: Reconsidering Treatment, Innovation, and Failure

Abstract Full Text
JAMA. 2019;322(11):1047-1048. doi:10.1001/jama.2019.12245

Evidence-Based Treatment for Mixed Urinary Incontinence

Abstract Full Text
JAMA. 2019;322(11):1049-1051. doi:10.1001/jama.2019.12659

Angiotensin Receptor–Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction

Abstract Full Text
JAMA. 2019;322(11):1051-1053. doi:10.1001/jama.2019.12662
JAMA Insights

Clinical Update

Adult Immunization Update

Abstract Full Text
has multimedia
JAMA. 2019;322(11):1096-1097. doi:10.1001/jama.2019.12739

This JAMA Insights Clinical Update reviews updates in 2019 to the Advisory Committee on Immunization Practices (ACIP) adult immunization schedule, including recommendations for the Shingrix vaccine for prevention of zoster and of the Heplisav-B vaccine for prevention of hepatitis B virus infection.

JAMA Clinical Challenge

Rapidly Progressive Vision Loss in a Patient With Breast Cancer

Abstract Full Text
has active quiz
JAMA. 2019;322(11):1098-1099. doi:10.1001/jama.2019.12691

A 67-year-old white female patient with metastatic breast cancer presented with 2 weeks of painless reduced vision in her right eye (OD), without headache, photophobia, diplopia, or eye pain, with placoid yellow choroidal lesions with ill-defined borders and subretinal fluid in each eye (OU). What is the diagnosis and what would you do next?

Medical News & Perspectives

Using Telemedicine to Treat Opioid Use Disorder in Rural Areas

Abstract Full Text
JAMA. 2019;322(11):1029-1031. doi:10.1001/jama.2019.12574

This Medical News story discusses the use of telemedicine to treat opioid use disorder in rural areas.

Quick Uptakes

Modest Calorie Reduction Can Improve Cardiometabolic Health

Abstract Full Text
JAMA. 2019;322(11):1032-1033. doi:10.1001/jama.2019.12314

This Medical News feature discusses research into the cardiometabolic benefits of a modest reduction in calorie intake.

News From the Food and Drug Administration

First Generics of Pregabalin

Abstract Full Text
JAMA. 2019;322(11):1036. doi:10.1001/jama.2019.14151

New Indications for Lyme Disease Tests

Abstract Full Text
JAMA. 2019;322(11):1036. doi:10.1001/jama.2019.13901

Textured Breast Implant Recall

Abstract Full Text
JAMA. 2019;322(11):1036. doi:10.1001/jama.2019.14152
The JAMA Forum

Nursing Our Way to Better Health

Abstract Full Text
free access
JAMA. 2019;322(11):1033-1034. doi:10.1001/jama.2019.13834
Global Health

Multidrug-Resistant Malaria Expands its Reach

Abstract Full Text
JAMA. 2019;322(11):1035. doi:10.1001/jama.2019.13075

African Women’s Preferences for HIV Prevention

Abstract Full Text
JAMA. 2019;322(11):1035. doi:10.1001/jama.2019.13825

Global Effect of Childhood Cancers

Abstract Full Text
JAMA. 2019;322(11):1035. doi:10.1001/jama.2019.13826
Poetry and Medicine

Dysthanasia

Abstract Full Text
JAMA. 2019;322(11):1110. doi:10.1001/jama.2019.5716
JAMA Revisited

Social Medicine, Medical Economics and Miscellany

Abstract Full Text
JAMA. 2019;322(11):1111. doi:10.1001/jama.2018.15517
JAMA Patient Page

Testosterone Deficiency

Abstract Full Text
free access
JAMA. 2019;322(11):1116. doi:10.1001/jama.2019.9290

This JAMA Patient Page describes the causes of testosterone deficiency as well as testing and treatment for it.

Comment & Response

Incorporating Intimate Partner Violence Interventions in Nurse Home Visitation Programs

Abstract Full Text
JAMA. 2019;322(11):1103. doi:10.1001/jama.2019.10598

Incorporating Intimate Partner Violence Interventions in Nurse Home Visitation Programs—Reply

Abstract Full Text
JAMA. 2019;322(11):1103-1104. doi:10.1001/jama.2019.10602

Incorporating Intimate Partner Violence Interventions in Nurse Home Visitation Programs—Reply

Abstract Full Text
JAMA. 2019;322(11):1104-1105. doi:10.1001/jama.2019.10606

Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation

Abstract Full Text
JAMA. 2019;322(11):1105. doi:10.1001/jama.2019.10680

Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation

Abstract Full Text
JAMA. 2019;322(11):1105-1106. doi:10.1001/jama.2019.10684

Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation—Reply

Abstract Full Text
JAMA. 2019;322(11):1106. doi:10.1001/jama.2019.10688

Optimal Gestational Weight Gain

Abstract Full Text
JAMA. 2019;322(11):1106-1107. doi:10.1001/jama.2019.10946

Optimal Gestational Weight Gain—Reply

Abstract Full Text
JAMA. 2019;322(11):1107-1108. doi:10.1001/jama.2019.10950
Correction

Error in Figure

Abstract Full Text
free access
JAMA. 2019;322(11):1108. doi:10.1001/jama.2019.12264

Deleted Footnote and Revised Footnote List in Table

Abstract Full Text
free access
JAMA. 2019;322(11):1108. doi:10.1001/jama.2019.12718

Incorrect Language in Figure and Text

Abstract Full Text
free access
JAMA. 2019;322(11):1108. doi:10.1001/jama.2019.12797
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2019;322(11):1027-1028. doi:10.1001/jama.2018.15510
×